Chemoinformaics analysis of GANODERIC-ACID-MH
| Molecular Weight | 544.773 | nRot | 7 |
| Heavy Atom Molecular Weight | 492.357 | nRig | 23 |
| Exact Molecular Weight | 544.376 | nRing | 4 |
| Solubility: LogS | -4.477 | nHRing | 0 |
| Solubility: LogP | 4.373 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 91 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 94.5952 |
| nHD | 2 | BPOL | 57.3748 |
| QED | 0.278 |
| Synth | 5.381 |
| Natural Product Likeliness | 3.006 |
| NR-PPAR-gamma | 0.937 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.112 |
| Pgp-sub | 0.003 |
| HIA | 0.136 |
| CACO-2 | -5.124 |
| MDCK | 0.0000177 |
| BBB | 0.688 |
| PPB | 0.989805 |
| VDSS | 1.196 |
| FU | 0.0341921 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.278 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.081 |
| CYP2c9-sub | 0.217 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.198 |
| CYP3a4-inh | 0.132 |
| CYP3a4-sub | 0.559 |
| CL | 3.165 |
| T12 | 0.02 |
| hERG | 0.003 |
| Ames | 0.008 |
| ROA | 0.142 |
| SkinSen | 0.014 |
| Carcinogencity | 0.019 |
| EI | 0.012 |
| Respiratory | 0.897 |
| NR-Aromatase | 0.81 |
| Antiviral | Yes |
| Prediction | 0.626351 |